Tianshilu: Loquat clear lung drink granule registration application is withdrawn

Tianshili announced that the company's application for the registration of loquat lung-clearing granules submitted in January 2024 has been approved for withdrawal by the National Medical Products Administration. The drug needs to further improve the application materials, so the company has decided to voluntarily withdraw the current drug registration application and will resubmit it after completing additional research. As of the date of the announcement, the company has invested a total of 11.3662 million yuan in research and development for this project. This withdrawal will not have a significant impact on the company's current and future production, operation, and performance.